Skip to main content

Collections open for submissions

New Content ItemAdvances in pre-clinical cancer models

Guest Edited by Ryan C. Fields and Anna Golebiewska

New Content ItemExtracellular vesicles in cancer progression

Guest Edited by: Orazio Fortunato, Irina Matei and Chunlin Ou

Editors Picks

New Content ItemEffects of urinary extracellular vesicles from prostate cancer patients on the transcriptomes of cancer-associated and normal fibroblasts

This article studies the effects of urinary EVs from PC patients and healthy males on the transcriptional landscape of prostate CAFs and normal foreskin fibroblasts.

New Content ItemOverall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis

This study aims to explore the impact of systematic re-excision (RE) as adjuvant care on overall survival (OS), local recurrence free survival (LRFS), and local and distant control (RFS) in patients with soft tissue sarcoma (STS).

New Content ItemSentinel lymph node mapping with superparamagnetic iron oxide for melanoma: a pilot study in healthy participants to establish an optimal MRI workflow protocol

This study shows the potential use of superparamagnetic iron oxide (SPIO) and pre-operative MRI in melanoma patients to identify SLNs. 

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!

Articles

Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions


Aims and Scope


BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

November - Pancreatic Cancer Awareness Month

July - Sarcoma Awareness Month

Pancreatic cancer accounts for about 3% of all cancers in the US and is projected to become the second leading cause of cancer-related death by 2030. 

On occasion of the Pancreatic Cancer Awareness Month we hope you will enjoy reading one of the newest study protocol published in BMC Cancer in 2022 aiming to enhance  chemosensitivity and drug distribution in pancreatic cancer through CAF conversion in the stroma.

New Content ItemSafety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that              reprograms the tumour stroma


Join our Editorial Board

New Content Item

Interested in joining the editorial board of BMC Cancer?

More information and how to apply can be found here. We are looking forward to hearing from you.

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact
    4.638 - 2-year Impact Factor (2021)
    4.672 - 5-year Impact Factor (2021)
    1.308 - SNIP (Source Normalized Impact per Paper)
    1.134 - SJR SCImago Journal Rank (SJR)

    Speed
    37 days to first decision for all manuscripts (Median)
    65 days to first decision for reviewed manuscripts only (Median)

    Usage 
    6,897,358 Downloads (2021)
    4,517 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal